Interleukin-2 on Active Dermatomyositis

Clinical trial NCT05495321 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05495321
Sponsor: Peking University People's Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 3
Study type: INTERVENTIONAL

Dermatomyositis

Start date: 2022-12-01
Primary completion: 2025-09-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.